Dimensions
DimensionsMutiah, Roihatul, Kristanti, Risma and Maimunah, Siti (2017) Synergistic Effects of Doxorubicin and Cardenolid Glycosides of Calotropis Gigantea Root on Cervical Cancer Hela Cell Line. Traditional Medicine Journal, 22 (2). pp. 116-123. ISSN 2406-9086
|
Text (full text)
2087.pdf - Published Version Download (10MB) | Preview |
Abstract
Cardenolid glycosides (CGs) has been known has high anticancer activity against several types of cancers, for example, breast cancer, lung cancer, prostate cancer, melanoma, neuroblastoma, myeloma and leukemia in the in vitro and in vivo research. The aim of our study was to know the synergistic potency of CGs improving the efficacy of doxorubicin in cervical cancer. Activities from combination of doxorubicin and CGs was measured by MTT colorimetric methode. Combination Index was used as combination efficacy parameter. The results showed that the IC50 of CGs was 1,023 μg/mL. CGs demonstrated selective activity in inhibiting the growth of HeLa cells by selectivity index > 3 (241.9). Combination test for CGs and Doxorubicin showed strong synergistic effect in doses 200 ug/mL Doxorubicin and 1.79 ug/mL CGs. The synergistic effect has been shown by 10 combination doses for the doses below the IC50. CGs increases the efficacy of Doxorubicin for the doses below the IC50, thus CGs can be recommended as co chemotherapy in cervical cancer treatment.
| Item Type: | Journal Article |
|---|---|
| Keywords: | Ko-kemoterapi; Glikosida cardenolid; Co-chemotherapy; Cardenolid glycosides (CGs); Calotropis gigantea; HeLa Cells Line |
| Subjects: | 11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis > 111204 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) |
| Divisions: | Faculty of Medical and Health Sciences > Department of Pharmacy |
| Depositing User: | Dr. M.Kes. Roihatul Muti'ah |
| Date Deposited: | 03 Sep 2017 08:41 |
Downloads
Downloads per month over past year
Origin of downloads
Actions (login required)
 |
View Item |
